Lumicell, an MIT spinout, has developed a handheld device with an optical imaging agent that enables surgeons to see real-time tissue images during surgery. This innovation helps detect residual cancer cells, allowing for more precise tissue removal and potentially reducing the need for follow-up surgeries. During clinical trials, the technology significantly decreased the need for second surgeries and identified tissue likely to contain cancer cells that standard lumpectomy procedures might have overlooked.
New device offers a real-time view of breast cancer during surgery
It eliminates the need for follow-up surgeries.
Explore more ..
Climate change impacting freshwater fish species
Climate change has had a definable impact on fish population dynamics.
A hybrid device to characterize the optical and hemodynamic properties
A first thyroid characterization through NIRS.
XLuminA automatically discovers experimental designs in microscopy
10,000 times faster than traditional methods.
Microscopic flowers to deliver medicines
A special class of particles delivers medicine through the bloodstream
De-normalizing sugar-sweetened beverage consumption
Effects of tax measures on social norms and attitudes.
The role of long-distance friendships in community conservation
Long-distance friendships can boost environmental conservation efforts.
Hair growth drug found to be effective in most cancer patients
There is indeed a safe way to regrow hair.
Transforming ultrathin Au films into 2D metallic nanostructures
Nanostructured two-dimensional gold monolayers.
Shape-changing haptic navigation device for vision impairment
It helps people with visual impairment perform a location task.